Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
暂无分享，去创建一个
E. Winer | R. Gelber | L. Trippa | Minetta C. Liu | R. Bose | B. Ramaswamy | V. Valero | H. Rugo | A. Wolff | H. Burstein | N. Tung | K. Marcom | William H. Barry | R. Nanda | L. Hart | K. Albain | D. Yardley | P. Pohlmann | S. Isakoff | Yue Zheng | K. Ruddy | A. Partridge | Shoshana M. Rosenberg | B. Schneider | T. Mulvey | V. Abramson | R. Barroso-Sousa | S. Tolaney | C. V. Van Poznak | V. Gadi | I. Krop | R. Jankowitz | A. Forero-Torres | P. Tarantino | N. Tayob | D. Weckstein | C. Dang | M. Rimawi | B. Ardman | A. Garrett | Kathryn E Reeder-Hayes | Kit Cheng | Jiani Hu | D. Zuckerman | Michael Constantine | Meredith Faggen | M. Demeo | F. Briccetti | P. Defusco | K. Reeder-Hayes
[1] N. Bishopric,et al. Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies , 2021, Breast Cancer Research and Treatment.
[2] R. Gelber,et al. A pooled analysis of the cardiac events in the trastuzumab adjuvant trials , 2019, Breast Cancer Research and Treatment.
[3] R. Barroso-Sousa,et al. De-escalating treatment in the adjuvant setting in HER2-positive breast cancer. , 2018, Future oncology.
[4] J. Cuzick,et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] M. Ellis,et al. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer. , 2016, JAMA oncology.
[6] J. R. Reeves,et al. Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer , 2003, The Journal of pathology.
[7] I. Ellis,et al. c-erbB-2 oncoprotein expression in primary and advanced breast cancer. , 1991, British Journal of Cancer.